COR

SELL

Cencora, Inc.

Healthcare · Rank #314 · Analyzed Oct 18, 2026

$340.92

Current Price

$337.19

Intrinsic Value

-1.1%

Upside/Downside

2/10

Score

2/5

Quality

Analysis Summary

Valuation Consensus0/2 methods agree

Quality Score2/5.0

Framework RatingSELL

Price vs Intrinsic ValueOvervalued by 1.1%

Fair Value Range

Low$106.75

Base (IV)$337.19

High$433.94

Entry Points

Conservative$74.73

Moderate$106.75

Aggressive$236.04

Quality & Moat Breakdown

Return on Equity96.9% → 1.0/1.0

Debt LevelD/E 447 → 0/1.0

Revenue QualityGrowth 9.1%, margin Δ+0.2% +recovery → 1.0/1.0

Moat Strength2.0/5 → 0/1.0

Profit Margins0.8% → 0/1.0

Methodology

This analysis uses a unified valuation framework combining three methods, Discounted Cash Flow (3-scenario), Earnings Power Value, and Asset Valuation, with a quality scoring overlay. A stock needs 2/3 valuation methods to agree and a quality score ≥ 3.5/5 for a BUY rating.

Learn how this framework works →

This is a personal analysis tool, not financial advice. Do your own research before making investment decisions.